{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibvbxd5eavsrw5fxqcgdqrnjfqofd2frgvo3jj2vvuzwf6a5swfv4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mk2idfgroil2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie3webipohb7gb3i22qr4itogy6xtdyyvhnddn6twnof4slnjivy4"
    },
    "mimeType": "image/jpeg",
    "size": 96878
  },
  "path": "/2026/04/21/roche-multiple-scleroris-efficacy-safety/?utm_campaign=rss",
  "publishedAt": "2026-04-21T23:15:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "autoimmune",
    "drug development",
    "Pharmaceuticals",
    "Roche",
    "STAT"
  ],
  "textContent": "The Swiss drugmaker Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company to seek approval.",
  "title": "STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom",
  "updatedAt": "2026-04-21T20:31:47.000Z"
}